N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 10, 2010, Pages 383-389

  Buyukhatipoglu, Hakan ^a   Sezen, Yusuf ^a   Yildiz, Ali ^a   Bas, Memduh ^a   Kirhan, Idris ^a   Ulas, Turgay ^a   Turan, Mehmet Nuri ^a   Taskin, Abdullah ^a   Aksoy, Nurten ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Contrast nephropathy; N acetylcysteine; Oxidative stress; Total antioxidant capacity; Total oxidant capacity

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM;

ADULT; ARTICLE; BLOOD SAMPLING; CHEMICAL PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; PERCUTANEOUS CORONARY INTERVENTION; SYSTOLIC BLOOD PRESSURE; TOTAL ANTIOXIDANT CAPACITY; TOTAL OXIDANT CAPACITY; URINALYSIS;

EID: 78650548520     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.975     Document Type: Article

References (21)

1. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol. 1994;5:125-137.
2. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005;68:14-22.
3. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The lohexol Cooperative Study. Kidney Int. 1995;47:254-261.
4. Heinrich MC, Kuhlmann MK, Grgic A, et al. Cytotoxic effects of ionic high-osmofar, nonionic monomelic, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology. 2005;235:843-849.
5. Kshirsagar AV, Poole C, Motti A, et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol. 2004;15:761-769.
6. Fishbane S. N acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol. 2008;3:281-287.
7. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103-1111.
8. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112-119.
9. Halliwell B, Guttridge JM. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy Lancet. 1984;1:1396-1397.
10. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence. Lancet. 1994;344:721-724.
11. Bakris GL, Lass N, Gaber AO, et al. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990;258: F115-F120.
12. Devrim E, Cetin M, Namuslu M, et al. Oxidant stress due to non ionic low osmolar contrast medium in rat kidney. Indian J Med Res. 2009;130:433-436.
13. Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity. Kidney Int. 2003;64:128-139.
14. Hizoh I, Halter C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol. 2002;37:428-434.
15. Katholi RE, Woods WT Jr, Taylor GJ, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32:64-71.
16. Rajbala, Sane AS, Upadhyay AR, et al. Iodinated contrast media induced oxidative stress in patients undergoing urography. Panminerva Med. 2000;42:119-122.
17. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patents with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol. 2002;40:1383-1388.
18. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA. 2003;289:553-558.
19. Durham JD, Caputo C, Dokko J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int. 2002;62:2202-2207.
20. Webb JG, Pate GE, Humphries KH, et al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J. 2004;148:422-429.
21. Coyle LC, Rodriguez A, Jeschke RE, et al. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Am Heart J. 2006;151:1039.e9-12.